Walter C Darbonne Selected Research

Walter C Darbonne Research Topics

10	Neoplasms (Cancer) 01/2022 - 08/2006
2	Thrombocytopenia (Thrombopenia) 01/2015 - 05/2014
2	Fatigue 05/2014 - 09/2009
2	Carcinogenesis 06/2011 - 03/2009
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Mesothelioma 11/2021
1	Disease Progression 11/2017
1	Multiple Myeloma 01/2016
1	Nausea 05/2014
1	Neutropenia 05/2014
1	Proteinuria 05/2014
1	Dysphonia (Spastic Dysphonia) 05/2014
1	Alopecia (Baldness) 05/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012
1	Medulloblastoma 04/2011
1	Basal Cell Carcinoma (Rodent Ulcer) 09/2009
1	Hyponatremia 09/2009
1	Atrial Fibrillation 09/2009
1	Spasm (Spasms) 09/2009
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 08/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2006

4	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2012
3	Bevacizumab (Avastin)FDA Link 01/2022 - 05/2014
3	Pharmaceutical PreparationsIBA 01/2016 - 09/2009
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 11/2012
2	atezolizumabIBA 01/2022 - 11/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 06/2011
2	LigandsIBA 06/2011 - 03/2009
2	HhAntag691IBA 04/2011 - 09/2009
1	Immune Checkpoint InhibitorsIBA 11/2021
1	monomethyl auristatin EIBA 11/2020
1	Circulating Tumor DNAIBA 11/2017
1	Bortezomib (Velcade)FDA Link 01/2016
1	navitoclaxIBA 01/2016
1	venetoclaxIBA 01/2016
1	Ado-Trastuzumab EmtansineIBA 01/2015
1	vesencumabIBA 05/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2014
1	Monoclonal AntibodiesIBA 05/2014
1	pyrrolidineIBA 12/2013
1	dacetuzumabIBA 08/2006